4-(9-ethyl-8-methyl-6H-pyrrolo[3,2-f]quinolin-7-yl)phenol;5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)pyridin-2-amine;5-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzene-1,3-diol;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzoic acid;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)phenol
C103H89N13O6 — CID 163992319
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(9-ethyl-8-methyl-6H-pyrrolo[3,2-f]quinolin-7-yl)phenol;5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)pyridin-2-amine;5-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzene-1,3-diol;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzoic acid;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)phenol
4-(9-ethyl-8-methyl-6H-pyrrolo[3,2-f]quinolin-7-yl)phenol;5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)pyridin-2-amine;5-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzene-1,3-diol;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzoic acid;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)phenol (PubChem CID 163992319) has the molecular formula C103H89N13O6 and a molecular weight of 1604.93 g/mol. Its IUPAC name is 4-(9-ethyl-8-methyl-6H-pyrrolo[3,2-f]quinolin-7-yl)phenol;5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)pyridin-2-amine;5-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzene-1,3-diol;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzoic acid;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)phenol.
Molecular Properties
| Compound Name | 4-(9-ethyl-8-methyl-6H-pyrrolo[3,2-f]quinolin-7-yl)phenol;5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)pyridin-2-amine;5-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzene-1,3-diol;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzoic acid;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)phenol |
|---|---|
| PubChem CID | 163992319 |
| Molecular Formula | C103H89N13O6 |
| Molecular Weight | 1604.93 g/mol |
| Exact Mass | 1603.71 |
| IUPAC Name | 4-(9-ethyl-8-methyl-6H-pyrrolo[3,2-f]quinolin-7-yl)phenol;5-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)pyridin-2-amine;5-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzene-1,3-diol;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)benzoic acid;4-(8,9,10,11-tetrahydro-6H-pyrrolo[3,2-a]phenanthridin-7-yl)phenol |
| SMILES | CCc1c(C)c(-c2ccc(O)cc2)[nH]c2ccc3nccc3c12.Nc1ccc(-c2nc3ccc4[nH]ncc4c3c3c2CCCC3)cn1.O=C(O)c1ccc(-c2[nH]c3ccc4nccc4c3c3c2CCCC3)cc1.Oc1cc(O)cc(-c2[nH]c3ccc4nccc4c3c3c2CCCC3)c1.Oc1ccc(-c2[nH]c3ccc4nccc4c3c3c2CCCC3)cc1 |
| InChI | InChI=1S/C22H18N2O2.C21H18N2O2.C21H18N2O.C20H18N2O.C19H17N5/c25-22(26)14-7-5-13(6-8-14)21-16-4-2-1-3-15(16)20-17-11-12-23-18(17)9-10-19(20)24-21;24-13-9-12(10-14(25)11-13)21-16-4-2-1-3-15(16)20-17-7-8-22-18(17)5-6-19(20)23-21;24-14-7-5-13(6-8-14)21-16-4-2-1-3-15(16)20-17-11-12-22-18(17)9-10-19(20)23-21;1-3-15-12(2)20(13-4-6-14(23)7-5-13)22-18-9-8-17-16(19(15)18)10-11-21-17;20-17-8-5-11(9-21-17)19-13-4-2-1-3-12(13)18-14-10-22-24-15(14)6-7-16(18)23-19/h5-12,24H,1-4H2,(H,25,26);5-11,23-25H,1-4H2;5-12,23-24H,1-4H2;4-11,22-23H,3H2,1-2H3;5-10H,1-4H2,(H2,20,21)(H,22,24) |
| InChIKey | MDFNVSROULQFBC-UHFFFAOYSA-N |
| XLogP | 23.19 |
| TPSA | 313.42 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 122 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1604.93 |
| LogP ≤ 5 | 23.19 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163992319 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.